Solar Foods (SFOODS) Investor update summary
Event summary combining transcript, slides, and related documents.
Investor update summary
10 Nov, 2026EU regulatory milestone
EFSA completed its scientific safety assessment and issued a positive opinion that Solein is safe under proposed conditions of use; Solein is the first gas-fermentation novel food ingredient to receive a positive EFSA opinion.
The European Commission must draft an implementing act, seek a Member State vote and publish the authorization; the remaining process is expected to take 7–9 months, with EU approval expected in 2027.
Final approval will define permitted food uses; 92% of positive EFSA opinions end in Commission authorization.
Market opportunity and demand
The addressable US and EU market is projected at €18bn by 2030, including ~€7bn in the EU and ~€11bn in the US, with ~8% annual growth.
Protein fortification is spreading into everyday foods and beverages; functional food launches grew 2–4x in 2026 vs. 2022, across categories including bars, drinks, ice cream and baked goods.
EU and US GLP-1 users could reach ~70m by 2030, potentially adding 250kt of annual protein demand; yogurt, meat snacks and nutrition bars are target categories.
Solein contains 80% protein, 10% fibre, 6% fat and 4% minerals; gas fermentation enables production independent of agricultural land, weather and climate, with consistent quality and year-round output.
Commercialization and partnerships
US commercialization is underway, with products in market; Ambrosia Collective reported Solein as a bestseller on its online channels and as its bestselling RTM protein powder.
EU product launches are planned for 2027, targeting CPG majors, health and performance brands, selected fast movers and distributors; several major European brands are in concept or recipe development.
Fazer is ready to launch Solein-containing products in Europe after final European Commission approval; pilots in Singapore and the US emphasized familiar formats, clear communication and consumer tasting.
The positive EFSA opinion is expected to accelerate existing opportunities, attract new prospects and move discussions with major food companies toward binding agreements.
Latest events from Solar Foods
- Revenue surged and funding strengthened expansion, but losses widened amid scaling efforts.SFOODS
H1 2026 - Commercialization accelerated, Factory 02 advanced, and funding secured amid strong protein demand.SFOODS
H2 2025 - Operating loss rose as new supply deals and Factory 02 planning advanced, cash declined.SFOODS
H1 2025 - Phased expansion and premium pricing drive sustainable protein toward profitability by 2030.SFOODS
CMD 2024 - Factory 01 operational, US GRAS status achieved, and strong funding supports global scaling.SFOODS
H1 2024 - Factory 01 launch, US approval, and Nasdaq listing drive growth focus; loss at EUR 11M.SFOODS
H2 2024